. Author manuscript; available in PMC: 2015 Nov 1.

Published in final edited form as: J Nucl Med. 2015 Apr 3;56(5):805–811. doi: 10.2967/jnumed.114.149054

TABLE 3.

Absorbed Fraction Doses (Gy/MBq) of ⁹⁰Y-DOTA-AR in Tumors/Kidneys

Mouse no.	Injected activity (MBq)	Peptide mass (ng)	Tumor	Kidney
1	0.74	40	0.45
2	0.74	40	0.35
3	0.74	40	0.21
			0.34 (average)
4	1.85	100	0.66
5	1.85	100	0.36
6	1.85	100	0.26
			0.43 (average)
7	3.7	200	0.26	0.05
8	3.7	200	0.36	0.05
9	3.7	200	0.44	0.07
			0.35 (average)	0.06 (average)
10	7.4	400	0.24	0.05
11	7.4	400	0.22	0.05
12	7.4	400	0.25	0.04
			0.24 (average)	0.05 (average)
13	18.5	1,000	0.23	0.08
14	18.5	1,000	0.28 0.26 (average)	0.06 0.07 (average)